Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00229255 · ClinicalTrials.gov registry record · NA

Relation of Obesity With Frequency of Meals (MST 0557)

A NA study of Obesity and Insulin Resistance, sponsored by Rockefeller University.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT00229255: Completed NA study of Obesity and Insulin Resistance, sponsored by Rockefeller University.

NCT00229255 is a NA study of Obesity and Insulin Resistance that has completed, run by Rockefeller University. The registered enrollment target is 22 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00229255, a NA study of Obesity and Insulin Resistance, has completed, sponsored by Rockefeller University.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the relationship between frequency of meals and hepatic fat content and insulin sensitivity. We, the researchers at Rockefeller University, hypothesize that low plasma insulin levels (as achieved by periods of fasting) will prevent insulin resistance and reduce hepatic lipid content. In contrast, frequent, carbohydrate-rich meals will predispose to hepatic steatosis (non-alcoholic) and insulin resistance. This is a 6 week inpatient study.

Interventions

  • OTHER high frequency of meals
  • OTHER twice a day meals

Study Locations (1)

New York

  • Rockefeller University Hospital - New York

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2005-03
Est. Completion 2009-06
Phase NA
Rockefeller University

117 total trials

What the finished NCT00229255 record still lists

NCT00229255 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower).

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which high frequency of meals is the first listed.

NCT00229255 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT00229255 about?

NCT00229255 is a clinical study titled "Relation of Obesity With Frequency of Meals (MST 0557)". The purpose of this study is to test the relationship between frequency of meals and hepatic fat content and insulin sensitivity. We, the researchers at Rockefeller University, hypothesize that low plasma insulin levels (as achieved by periods of fasting) will prevent insulin resistance and reduce h...

What is the current status of trial NCT00229255?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2005-03. Estimated completion is 2009-06.

What conditions does trial NCT00229255 study?

This clinical trial studies the following conditions: Obesity, Insulin Resistance, Fatty Liver.

What interventions are being tested in trial NCT00229255?

The interventions under investigation include: high frequency of meals (OTHER), twice a day meals (OTHER).

Who is sponsoring clinical trial NCT00229255?

This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00229255 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00229255's enrollment target sits among peer trials

22 935th of 1053 higher than 116 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00229255, the US trial registry maintained by the National Library of Medicine. NCT00229255 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.